Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

If you are wondering whether CRISPR Therapeutics at about US$53.84 is still priced attractively or already baking in a lot of ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Researchers from Würzburg, Braunschweig, and the US identifiy Cas12a3 nuclease showing precise activity. Their study is ...